Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1046 entries
Sorted by: Best Match Show Resources per page
A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management.

Journal of clinical and diagnostic research : JCDR

Raj HJ, Majumdar B, Jain A, Maiti PK, Chatterjee G.
PMID: 26816977
J Clin Diagn Res. 2015 Dec;9(12):WC01-4. doi: 10.7860/JCDR/2015/16199.6963. Epub 2015 Dec 01.

INTRODUCTION: Verrucous plaques mimicking chromoblastomycosis are frequently seen in dermatology outpatient departments (OPD). However, no scientific evaluation has been carried out till date from eastern India. So this present endeavour is aimed at a thorough study of those cases...

Cite
Raj HJ, Majumdar B, Jain A, et al. A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management. J Clin Diagn Res. 2015;9(12):WC01-4doi: 10.7860/JCDR/2015/16199.6963.
Raj, H. J., Majumdar, B., Jain, A., Maiti, P. K., & Chatterjee, G. (2015). A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management. Journal of clinical and diagnostic research : JCDR, 9(12), WC01-4. https://doi.org/10.7860/JCDR/2015/16199.6963
Raj, Hirak Jyoti, et al. "A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management." Journal of clinical and diagnostic research : JCDR vol. 9,12 (2015): WC01-4. doi: https://doi.org/10.7860/JCDR/2015/16199.6963
Raj HJ, Majumdar B, Jain A, Maiti PK, Chatterjee G. A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management. J Clin Diagn Res. 2015 Dec;9(12):WC01-4. doi: 10.7860/JCDR/2015/16199.6963. Epub 2015 Dec 01. PMID: 26816977; PMCID: PMC4717751.
Copy Download .nbib Format: NLM
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.

Tanaffos

Ansarin K, Attaran D, Jamaati H, Masjedi MR, Abtahi H, Alavi A, Aliyali M, Asnaashari AM, Farid-Hosseini R, Ghayumi SM, Ghobadi H, Ghotb A, Halvani A, Nemati A, Rahimi Rad MH, Rahimian M, Sami R, Sohrabpour H, Tavana S, Torabi-Nami M, Vahedi P.
PMID: 26528362
Tanaffos. 2015;14(2):73-94.

Challenges in the assessment, diagnosis and management of severe, difficult-to-control asthma are increasingly regarded as clinical needs yet unmet. The assessments required to determine asthma severity, comorbidities and confounding factors, disease phenotypes and optimal treatment are among the controversial...

Cite
Ansarin K, Attaran D, Jamaati H, et al. Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. Tanaffos. 2015;14(2):73-94
Ansarin, K., Attaran, D., Jamaati, H., Masjedi, M. R., Abtahi, H., Alavi, A., Aliyali, M., Asnaashari, A. M., Farid-Hosseini, R., Ghayumi, S. M., Ghobadi, H., Ghotb, A., Halvani, A., Nemati, A., Rahimi Rad, M. H., Rahimian, M., Sami, R., Sohrabpour, H., Tavana, S., Torabi-Nami, M., & Vahedi, P. (2015). Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. Tanaffos, 14(2), 73-94.
Ansarin, Khalil, et al. "Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran." Tanaffos vol. 14,2 (2015): 73-94.
Ansarin K, Attaran D, Jamaati H, Masjedi MR, Abtahi H, Alavi A, Aliyali M, Asnaashari AM, Farid-Hosseini R, Ghayumi SM, Ghobadi H, Ghotb A, Halvani A, Nemati A, Rahimi Rad MH, Rahimian M, Sami R, Sohrabpour H, Tavana S, Torabi-Nami M, Vahedi P. Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. Tanaffos. 2015;14(2):73-94. PMID: 26528362; PMCID: PMC4629434.
Copy Download .nbib Format: NLM
A paradigm for the evaluation and management of spinal coccidioidomycosis.

Surgical neurology international

Martirosyan NL, Skoch JM, Zaninovich O, Zoccali C, Galgiani JN, Baaj AA.
PMID: 26167359
Surg Neurol Int. 2015 Jun 17;6:107. doi: 10.4103/2152-7806.158979. eCollection 2015.

BACKGROUND: Coccidioidomycosis is a fungal infection that is endemic to parts of the Southwestern United States. When infection involves the spine, the treatment strategies can be challenging. We have devised a management protocol for spinal coccidioidomycosis based on a...

Cite
Martirosyan NL, Skoch JM, Zaninovich O, et al. A paradigm for the evaluation and management of spinal coccidioidomycosis. Surg Neurol Int. 2015;6:107doi: 10.4103/2152-7806.158979.
Martirosyan, N. L., Skoch, J. M., Zaninovich, O., Zoccali, C., Galgiani, J. N., & Baaj, A. A. (2015). A paradigm for the evaluation and management of spinal coccidioidomycosis. Surgical neurology international, 6107. https://doi.org/10.4103/2152-7806.158979
Martirosyan, Nikolay L, et al. "A paradigm for the evaluation and management of spinal coccidioidomycosis." Surgical neurology international vol. 6 (2015): 107. doi: https://doi.org/10.4103/2152-7806.158979
Martirosyan NL, Skoch JM, Zaninovich O, Zoccali C, Galgiani JN, Baaj AA. A paradigm for the evaluation and management of spinal coccidioidomycosis. Surg Neurol Int. 2015 Jun 17;6:107. doi: 10.4103/2152-7806.158979. eCollection 2015. PMID: 26167359; PMCID: PMC4483783.
Copy Download .nbib Format: NLM
Isolation of two highly methylated polyketide derivatives from a yew-associated penicillium species.

Journal of natural products

Stierle DB, Stierle AA, Ganser BK.
PMID: 10479323
J Nat Prod. 1999 Aug;62(8):1147-50. doi: 10.1021/np980510v.

Two selective antifungal agents were produced by a Penicillium sp. isolated from the inner bark of the Pacific yew tree, Taxus brevifolia. The structures of these highly methylated polyketide derivatives were deduced by detailed analysis of both 1D and...

Cite
Stierle DB, Stierle AA, Ganser BK. Isolation of two highly methylated polyketide derivatives from a yew-associated penicillium species. J Nat Prod. 1999;62(8):1147-50doi: 10.1021/np980510v.
Stierle, D. B., Stierle, A. A., & Ganser, B. K. (1999). Isolation of two highly methylated polyketide derivatives from a yew-associated penicillium species. Journal of natural products, 62(8), 1147-50. https://doi.org/10.1021/np980510v
Stierle, et al. "Isolation of two highly methylated polyketide derivatives from a yew-associated penicillium species." Journal of natural products vol. 62,8 (1999): 1147-50. doi: https://doi.org/10.1021/np980510v
Stierle DB, Stierle AA, Ganser BK. Isolation of two highly methylated polyketide derivatives from a yew-associated penicillium species. J Nat Prod. 1999 Aug;62(8):1147-50. doi: 10.1021/np980510v. PMID: 10479323.
Copy Download .nbib Format: NLM
The role of murine models in the development of antifungal therapy for systemic mycoses.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Graybill JR.
PMID: 11498404
Drug Resist Updat. 2000 Dec;3(6):364-383. doi: 10.1054/drup.2000.0171.

Animal testing is crucial to the development of new antifungal compounds. This review describes the role that murine and other animal models have played in the development of three classes of antifungal agents: the polyenes, the triazoles and the...

Cite
Graybill JR. The role of murine models in the development of antifungal therapy for systemic mycoses. Drug Resist Updat. 2000;3(6):364-383doi: 10.1054/drup.2000.0171.
Graybill, J. R. (2000). The role of murine models in the development of antifungal therapy for systemic mycoses. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 3(6), 364-383. https://doi.org/10.1054/drup.2000.0171
Graybill, John R.. "The role of murine models in the development of antifungal therapy for systemic mycoses." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 3,6 (2000): 364-383. doi: https://doi.org/10.1054/drup.2000.0171
Graybill JR. The role of murine models in the development of antifungal therapy for systemic mycoses. Drug Resist Updat. 2000 Dec;3(6):364-383. doi: 10.1054/drup.2000.0171. PMID: 11498404.
Copy Download .nbib Format: NLM
Antifungal agents.

Developments in ophthalmology

[No authors listed]
PMID: 10641211
Dev Ophthalmol. 1999;32:27-51. doi: 10.1159/000060769.

No abstract available.

Cite
Antifungal agents. Dev Ophthalmol. 1999;32:27-51doi: 10.1159/000060769.
(1999). Antifungal agents. Developments in ophthalmology, 3227-51. https://doi.org/10.1159/000060769
"Antifungal agents." Developments in ophthalmology vol. 32 (1999): 27-51. doi: https://doi.org/10.1159/000060769
Antifungal agents. Dev Ophthalmol. 1999;32:27-51. doi: 10.1159/000060769. PMID: 10641211.
Copy Download .nbib Format: NLM
Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Maesaki S, Kawamura S, Miyazaki Y, Tomono K, Tashiro T, Kohno S.
PMID: 11810503
J Infect Chemother. 1999 Sep;5(3):125-129. doi: 10.1007/s101560050021.

Patients with aspergillosis have a poor prognosis because there are no effective antifungal agents except for amphotericin B. However, administration of amphotericin B is limited in immunocompromised patients due to its toxicity, which includes impairment of renal function. We...

Cite
Maesaki S, Kawamura S, Miyazaki Y, et al. Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus. J Infect Chemother. 1999;5(3):125-129doi: 10.1007/s101560050021.
Maesaki, S., Kawamura, S., Miyazaki, Y., Tomono, K., Tashiro, T., & Kohno, S. (1999). Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 5(3), 125-129. https://doi.org/10.1007/s101560050021
Maesaki, S., et al. "Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus." Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy vol. 5,3 (1999): 125-129. doi: https://doi.org/10.1007/s101560050021
Maesaki S, Kawamura S, Miyazaki Y, Tomono K, Tashiro T, Kohno S. Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus. J Infect Chemother. 1999 Sep;5(3):125-129. doi: 10.1007/s101560050021. PMID: 11810503.
Copy Download .nbib Format: NLM
Review: antifungal agents do not reduce mortality in neutropenia caused by chemotherapy or bone marrow transplantation.

ACP journal club

Rotstein C.
PMID: 12418838
ACP J Club. 2002 Nov-Dec;137(3):98.

No abstract available.

Cite
Rotstein C. Review: antifungal agents do not reduce mortality in neutropenia caused by chemotherapy or bone marrow transplantation. ACP J Club. 2002;137(3):98
Rotstein, C. (2002). Review: antifungal agents do not reduce mortality in neutropenia caused by chemotherapy or bone marrow transplantation. ACP journal club, 137(3), 98.
Rotstein, Coleman. "Review: antifungal agents do not reduce mortality in neutropenia caused by chemotherapy or bone marrow transplantation." ACP journal club vol. 137,3 (2002): 98.
Rotstein C. Review: antifungal agents do not reduce mortality in neutropenia caused by chemotherapy or bone marrow transplantation. ACP J Club. 2002 Nov-Dec;137(3):98. PMID: 12418838.
Copy Download .nbib Format: NLM
[Human infections by black yeasts of genus Exophiala].

Revista iberoamericana de micologia

García-Martos P, Márquez A, Gené J.
PMID: 12828507
Rev Iberoam Micol. 2002 Jun;19(2):72-9.

Clinical and laboratory aspects of the infections caused by Exophiala species are reviewed with regard to its epidemiology, diagnosis and treatment. Exophiala is a genus of dematiaceous hyphomycetes whose taxonomy and nomenclature undergo constant revision. Exophiala species are widely...

Cite
García-Martos P, Márquez A, Gené J. Infecciones humanas por levaduras negras del género Exophiala. [Human infections by black yeasts of genus Exophiala]. Rev Iberoam Micol. 2002;19(2):72-9
García-Martos, P., Márquez, A., & Gené, J. (2002). Infecciones humanas por levaduras negras del género Exophiala. [Human infections by black yeasts of genus Exophiala]. Revista iberoamericana de micologia, 19(2), 72-9.
García-Martos, Pedro, et al. "Infecciones humanas por levaduras negras del género Exophiala." [Human infections by black yeasts of genus Exophiala]. Revista iberoamericana de micologia vol. 19,2 (2002): 72-9.
García-Martos P, Márquez A, Gené J. Infecciones humanas por levaduras negras del género Exophiala. [Human infections by black yeasts of genus Exophiala]. Rev Iberoam Micol. 2002 Jun;19(2):72-9. Spanish. PMID: 12828507.
Copy Download .nbib Format: NLM
Dermatology for the practicing allergist: Tinea pedis and its complications.

Clinical and molecular allergy : CMA

Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswamy G.
PMID: 15050029
Clin Mol Allergy. 2004 Mar 29;2(1):5. doi: 10.1186/1476-7961-2-5.

Tinea pedis is a chronic fungal infection of the feet, very often observed in patients who are immuno-suppressed or have diabetes mellitus. The practicing allergist may be called upon to treat this disease for various reasons. Sometimes tinea infection...

Cite
Al Hasan M, Fitzgerald SM, Saoudian M, et al. Dermatology for the practicing allergist: Tinea pedis and its complications. Clin Mol Allergy. 2004;2(1):5doi: 10.1186/1476-7961-2-5.
Al Hasan, M., Fitzgerald, S. M., Saoudian, M., & Krishnaswamy, G. (2004). Dermatology for the practicing allergist: Tinea pedis and its complications. Clinical and molecular allergy : CMA, 2(1), 5. https://doi.org/10.1186/1476-7961-2-5
Al Hasan, Muhannad, et al. "Dermatology for the practicing allergist: Tinea pedis and its complications." Clinical and molecular allergy : CMA vol. 2,1 (2004): 5. doi: https://doi.org/10.1186/1476-7961-2-5
Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswamy G. Dermatology for the practicing allergist: Tinea pedis and its complications. Clin Mol Allergy. 2004 Mar 29;2(1):5. doi: 10.1186/1476-7961-2-5. PMID: 15050029; PMCID: PMC419368.
Copy Download .nbib Format: NLM
Drug resistance in Cryptococcus neoformans.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Perfect JR, Cox GM.
PMID: 11504497
Drug Resist Updat. 1999 Aug;2(4):259-269. doi: 10.1054/drup.1999.0090.

Cryptococcus neoformans has become a major opportunistic fungal pathogen worldwide. Successful treatment of invasive disease with this fungus has used amphotericin B, flucytosine and various azoles. However, treatment failures continue to occur for a variety of reasons including direct...

Cite
Perfect JR, Cox GM. Drug resistance in Cryptococcus neoformans. Drug Resist Updat. 1999;2(4):259-269doi: 10.1054/drup.1999.0090.
Perfect, J. R., & Cox, G. M. (1999). Drug resistance in Cryptococcus neoformans. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2(4), 259-269. https://doi.org/10.1054/drup.1999.0090
Perfect, John R., and Cox, Gary M.. "Drug resistance in Cryptococcus neoformans." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 2,4 (1999): 259-269. doi: https://doi.org/10.1054/drup.1999.0090
Perfect JR, Cox GM. Drug resistance in Cryptococcus neoformans. Drug Resist Updat. 1999 Aug;2(4):259-269. doi: 10.1054/drup.1999.0090. PMID: 11504497.
Copy Download .nbib Format: NLM
Antifungal drug susceptibility testing and resistance in Aspergillus.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Warnock DW, Arthington-Skaggs BA, Li RK.
PMID: 11504507
Drug Resist Updat. 1999 Oct;2(5):326-334. doi: 10.1054/drup.1999.0092.

Aspergillus species are the most common causes of invasive mold infections in immunocompromised patients. The introduction of new antifungal agents, and recent reports of resistance emerging during treatment of aspergillus infections, have highlighted the need for standardized methods of...

Cite
Warnock DW, Arthington-Skaggs BA, Li RK. Antifungal drug susceptibility testing and resistance in Aspergillus. Drug Resist Updat. 1999;2(5):326-334doi: 10.1054/drup.1999.0092.
Warnock, D. W., Arthington-Skaggs, B. A., & Li, R. K. (1999). Antifungal drug susceptibility testing and resistance in Aspergillus. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2(5), 326-334. https://doi.org/10.1054/drup.1999.0092
Warnock, David W., et al. "Antifungal drug susceptibility testing and resistance in Aspergillus." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 2,5 (1999): 326-334. doi: https://doi.org/10.1054/drup.1999.0092
Warnock DW, Arthington-Skaggs BA, Li RK. Antifungal drug susceptibility testing and resistance in Aspergillus. Drug Resist Updat. 1999 Oct;2(5):326-334. doi: 10.1054/drup.1999.0092. PMID: 11504507.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1046 entries